About this data
What it is
The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
Who files it
The USPTO publishes each grant.
How current
Grants are published every Tuesday, and we collect them weekly.
Worth knowing
A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.

All of this comes from public filings.

Patents granted per week, last 12 weeks

05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10
05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10

Latest patent grants

Reset

Showing: ticker AVXL

Latest patent grants
GrantedPatentOwnerTypeSource
Oct 13, 202612759986
Crystal forms of tetrahydro-N, N-dimethyl-2,2-diphenyl-3-furanmethana…
AVXL
Anavex Life Sciences Corp.
utilityGoogle Patents ↗
Sep 15, 202612734147
Neurodevelopmental disorder therapy
AVXL
Anavex Life Sciences Corp.
utilityGoogle Patents ↗
Jun 2, 202612642784
ANAVEX2-73 for the treatment of genetic neurodevelopmental disorders
AVXL
Anavex Life Sciences Corp.
utilityGoogle Patents ↗
Apr 7, 202612594256
A19-144, A2-73 and certain anticholinesterase inhibitor compositions…
AVXL
Anavex Life Sciences Corp.
utilityGoogle Patents ↗
Feb 24, 202612558340
ANAVEX2-73 for the treatment of genetic neurodevelopmental disorders
AVXL
Anavex Life Sciences Corp.
utilityGoogle Patents ↗
Jan 27, 202612533352
Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl)(…
AVXL
Anavex Life Sciences Corp.
utilityGoogle Patents ↗
Aug 12, 202512383526
Optimized sigma-1 agonist method of responder selection and treatment
AVXL
Anavex Life Sciences Corp.
utilityGoogle Patents ↗
Apr 29, 202512285403
A2-73 as a therapeutic for insomnia, anxiety and agitation
AVXL
Anavex Life Sciences Corp.
utilityGoogle Patents ↗
Apr 22, 202512280034
Sigma-1 receptor agonist systolic blood pressure therapy
AVXL
Anavex Life Sciences Corp.
utilityGoogle Patents ↗
Jan 28, 202512208079
Enantiomers of A2-73, analogues, and sigma agonist activity
AVXL
Anavex Life Sciences Corp.
utilityGoogle Patents ↗
Dec 31, 202412180174
A2-73 crystalline polymorph compositions of matter and methods of use…
AVXL
Anavex Life Sciences Corp.
utilityGoogle Patents ↗
Nov 12, 202412138240
Treatment of cardiac dysfunction
AVXL
Anavex Life Sciences Corp.
utilityGoogle Patents ↗

12 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:14 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances